Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
09/2009
09/11/2009WO2009110939A2 Drug delivery system for pharmaceuticals and radiation
09/11/2009WO2009109332A1 Bombesin analog peptide antagonist conjugates
09/11/2009WO2009109327A2 Method and product for obtaining thin radioactive layers to be used in radiation dosimetry and in medicine
09/11/2009CA2717427A1 Bombesin analog peptide antagonist conjugates
09/10/2009US20090227686 Methods of preventing, treating and diagnosing disorders of protein aggregation
09/10/2009US20090226369 STQ Peptides
09/10/2009US20090226368 Androgen-Receptor (AR) Ligands for Use in the Treatment and Diagnosis of AR-Related Pathologies
09/10/2009US20090226367 Compositions comprising an anti-ca125 antibody and a cytotoxic compound and their use for the treatment of cancer
09/10/2009US20090226366 Choline: Early Detector of Cancer
09/09/2009EP2098523A1 Novel compounds with affinity for amyloid
09/09/2009EP2098514A1 Preparation of compounds useful for the detection of hypoxia
09/09/2009EP2098251A1 Method and product for obtaining thin radioactive layers to be used in radiation dosimetry and in medicine
09/09/2009EP2097112A2 Methods of imaging employing chelating agents
09/09/2009EP2097111A2 Heterodimers of glutamic acid
09/09/2009EP1648925B1 Bicyclic peptide imaging agents
09/09/2009EP1517918B9 Peptides having affinity for a phospholipid and uses
09/09/2009CN101528270A 68ga-labeled peptide-based radiopharmaceuticals
09/09/2009CN101528269A Preparation and utility of opioid analgesics
09/09/2009CN101524549A New anti-cancer compound
09/09/2009CN100536926C Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
09/08/2009US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy
09/08/2009US7585839 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others
09/08/2009US7585509 Erb-2 receptor targeting peptide
09/08/2009US7585492 Contrast agents used in various embodiments may be any organic or semi-organic compounds which have the desired effect of affinity to certain target tissues/cells to either bind with them or react with them or react with metabolic products of the target; dosage monitoring and therapy success mechanism
09/08/2009CA2284750C Steroid sulfamates, method for the production and use thereof
09/07/2009CA2624883A1 Directed therapy
09/03/2009WO2009107139A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
09/03/2009WO2009106566A2 Therapy selection method
09/03/2009WO2009089383A3 Inhibitors of carbonic anhydrase ix
09/03/2009WO2009027452A3 Radiopharmaceutical composition
09/03/2009WO2008148877A3 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function
09/03/2009WO2008145283A3 Use of radiolabelled phenyloxyaniline derivatives for imaging diseases associated with peripheral benzodiazepin receptor's activation
09/03/2009WO2008112224A3 High radioactivity thallium solutions and uses thereof
09/03/2009US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer
09/03/2009US20090220420 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
09/03/2009US20090220419 99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS
09/03/2009US20090220418 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity
09/03/2009US20090220417 Methods of using il-31 monoclonal antibodies to reduce inflammation
09/03/2009US20090220416 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders
09/03/2009US20090220415 Diagnostic system for the detection of skin cancer
09/03/2009CA2717060A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
09/02/2009EP2094311A2 Improved linkers for anchoring targeting ligands
09/02/2009EP0995448B1 Compound for diagnosing malignant tumors
09/02/2009CN101518651A Pastille slow-release material and preparation method and application thereof
09/02/2009CN100535013C Selective targeting of tumor vasculature using antibody molecules
09/02/2009CN100534535C Improved linkers for pharmaceutical compounds
09/01/2009US7582440 Imaging, diagnosis and treatment of disease
09/01/2009US7582295 Glycoprotein receptor complex; cancer therapy
09/01/2009US7582281 Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging
09/01/2009US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
09/01/2009US7582279 Surface modified lipoprotein-like oil in water emulsion having lipophilic core surrounded by monolayer of amphiphilic or polar lipids; polyoxyethylene glycol linked lipid and (choles)terol; radioactive or stable, synthetic polyhalogenated triglycerides as contrast agents; radiographic imaging
08/2009
08/27/2009US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
08/27/2009US20090214425 Tumor therapy with replication competent sindbis viral vectors
08/27/2009US20090214424 Human glycoprotein hormone superagonists and uses thereof
08/27/2009US20090214423 Selective targeting of tumor vasculature using radiolabelled antibody molecules
08/27/2009US20090214422 DNA encoding a novel RG1 polypeptide
08/27/2009US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
08/27/2009US20090214420 Method of Diagnosis and Treatment and Agents Useful for Same
08/27/2009US20090214419 Self-assembled biodegradable polymersomes
08/27/2009CA2715747A1 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging
08/26/2009EP2092058A1 Cancerous disease modifying antibodies
08/26/2009EP2091453A2 A system, method, computer-readable medium, and use for planning combined therapy
08/26/2009CN101516408A Method for radiolabeling formulations for gamma scintigraphy assesment
08/26/2009CN101516407A Improvement of arginase levels/activity
08/26/2009CN100531798C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
08/25/2009US7579313 Transglutaminase inhibitors and methods of use thereof
08/20/2009WO2009102384A2 Radiolabeled derivatives of potent chymase inhibitors
08/20/2009WO2009102378A2 Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals
08/20/2009US20090208414 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled ketones by photo-induced free radical carbonylation
08/20/2009US20090208413 Registry Method and Control System for Dea Schedule II-V Medicines
08/20/2009US20090208412 Contrast Agents
08/20/2009US20090208411 Cytotoxicity mediation of cells evidencing surface expression of CD44
08/20/2009US20090208410 Ed-b fibronectin as stratification marker for anti-tumor drugs
08/20/2009US20090208409 Encapsulated nanoparticles for computed tomography imaging
08/20/2009US20090208408 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases
08/19/2009EP2089514A1 Cancerous disease modifying antibodies
08/19/2009EP2089362A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof
08/19/2009EP1933885B1 Automated radiolabelling method
08/19/2009EP1740225A4 Contrast agents for myocardial perfusion imaging
08/19/2009EP1463065B9 Processes for producing 15o-carbon monoxide and 15o-carbon dioxide and production apparatus
08/19/2009EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
08/19/2009EP1119356B1 Radiolabeled neurokinin-1 receptor antagonists
08/19/2009EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses
08/19/2009CN101511389A Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition
08/19/2009CN100528242C Radioactive macroaggregate and its preparation method
08/19/2009CN100528241C Vitamin-targeted imaging agents
08/18/2009US7575873 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis
08/18/2009US7575738 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
08/18/2009CA2413736C Thorium or actinium radionuclides for endoradionuclide therapy
08/13/2009WO2009100014A1 System for fluorinating organic compounds
08/13/2009WO2009099636A1 Conjugation of small molecules to octaarginine transporters for overcoming multi-drug resistance
08/13/2009WO2009018175A3 Cyclic azapeptides as integrin markers
08/13/2009WO2009000777A3 Imaging diagnostics by combining contrast agents
08/13/2009US20090203584 Peptide-based Compounds
08/13/2009US20090203024 Secreted protein called 36p6d5 characteristic of tumors
08/13/2009US20090202436 Bupivacaine Formulation in a Polyorthoester Carrier
08/13/2009US20090202435 Diagnostic compounds for targeting a chemokine receptors
08/13/2009US20090202434 Pharmaceutical Composition and Dressing for Treating Skin Lesion, as Well as the Use of Cerium Salt Associated With a Collagen Matrix
08/13/2009US20090202433 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
08/13/2009US20090202432 Treatment and prophylaxis of amyloidosis
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 243